Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

I remember last October 2013 when we were all wait

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30066
Posted On: 12/04/2014 1:12:49 PM
Posted By: Daveludlow
I remember last October 2013 when we were all waiting for the Becton Dickenson validation. Finally, when everyone's nerves were frayed, Gerald tweeted saying he and Adam Simons were presently at Beckton Dickenson having a discussion with their marketing people about Lympro's launch in 2014. He reassured us that Lympro was on target. Then in at the LA Conference in December Gerald referred to Becton Dickenson as our "partner."

Those "intimations" excited the troops back in the Fall of 2013, stoking expectations for 2014. I remember asking Gerald on a CC in November about that .10 cent thing and being there for over 20 consecutive days before we got the necessary funding. Gerald told me that he wouldn't have structured that deal unless he were confident that the catalysts they had would get us over. Yet, here we are 13 months later still trading at .09 cents.

So, even though Gerald's "intimations" are exciting, I've been down that road before. I was his biggest promoter up until this September. Now, I am going to wait to get excited by anything he says....until he actually delivers it!!

"LymPro revenues will change the math" and "we'll get a significant portion of 150 million" are pretty vague revenue guidance. And as for the objections, "well he is in negotiations with a partner or a buyer for Lympro and can't be any more specific." Well, we've heard that before too, many times!

I'm not saying December and January won't be great months for us. I am hoping they will. I have just learned from experience to keep my expectations in check when it comes to Gerald's "intimations."


(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us